1995
DOI: 10.1172/jci118138
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin 4 activates a signal transducer and activator of transcription (Stat) protein which interacts with an interferon-gamma activation site-like sequence upstream of the I epsilon exon in a human B cell line. Evidence for the involvement of Janus kinase 3 and interleukin-4 Stat.

Abstract: Germ line CQ transcripts can be induced by 1L-4 in the human B cell line, BL-2. Utilizing a IFN-y activation sitelike DNA sequence element located upstream of the L exon, we demonstrated by gel mobility shift assays that IL-4 induced a binding activity in the cytosol and nucleus of BL-2 cells. This factor was designated 1L4 NAF (IL-4-induced nuclear-activating factors) and was identified as a tyrosine phosphoprotein, which translocates from the cytosol to the nucleus upon 11-4 treatment. Because these are the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
27
0

Year Published

1996
1996
2013
2013

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 54 publications
(28 citation statements)
references
References 41 publications
1
27
0
Order By: Relevance
“…Site 1 and 2 sequences were from the P-selectin promoter, and the I⑀ core Stat6 sequence (italicized) was from the immunoglobulin ⑀ (I⑀) promoter that was previously shown to bind Stat6. 25 The mut sequence contained mutations in the site 1 core sequence that rendered it unable to bind Stat6 (data not shown). The ␤-cas sequence is the interferon-␥ activation site-like sequence (GAS) element from the ␤-casein promoter, which binds Stat5 26 and acts as a general STAT-binding site (Y.K-G. et al, unpublished observations, 1998, and Reference 27).…”
Section: Synthetic Oligonucleotides and Plasmid Constructsmentioning
confidence: 98%
See 2 more Smart Citations
“…Site 1 and 2 sequences were from the P-selectin promoter, and the I⑀ core Stat6 sequence (italicized) was from the immunoglobulin ⑀ (I⑀) promoter that was previously shown to bind Stat6. 25 The mut sequence contained mutations in the site 1 core sequence that rendered it unable to bind Stat6 (data not shown). The ␤-cas sequence is the interferon-␥ activation site-like sequence (GAS) element from the ␤-casein promoter, which binds Stat5 26 and acts as a general STAT-binding site (Y.K-G. et al, unpublished observations, 1998, and Reference 27).…”
Section: Synthetic Oligonucleotides and Plasmid Constructsmentioning
confidence: 98%
“…First, the binding was completely abolished by the addition of a cold competitor oligonucleotide (denoted I⑀) containing the Stat6-binding site of the I⑀ promoter, which had previously been demonstrated to efficiently bind Stat6. 25 In contrast, an oligonucleotide probe with a mutation in the Stat6 consensus sequence (denoted mut) was unable to compete for binding to either site 1 or site 2 probes even when added at 100-fold molar excess. This finding suggests that the IL-4 -inducible factor was specifically binding to both of the canonical Stat6 sequences of the P-selectin promoter.…”
Section: P-selectin Promoter Binds Stat6 Induced By Il-4mentioning
confidence: 99%
See 1 more Smart Citation
“…IL-4 has also been shown to induce transcription factor STAT6 binding to a GAS element in the monocytic cell line THP-1 55,58 and in the B cell line BL-2. 59 In B-CLL cells, STAT-1 is activated 60 and STAT-6 nuclear translocation is induced by IL-4. 61 Therefore, taken together, these studies suggest that constitutive and cytokine-induced NOS2 expression in B-CLL cells may be regulated by STAT-1, STAT-6 and NOS2 GAS promoter elements at the transcriptional level.…”
Section: Leukemiamentioning
confidence: 99%
“…Latent STAT6 is activated in the cytoplasm by tyrosine phosphorylation. In its activated state, it can dimerize, translocate to the nucleus, and bind to a specific DNA sequence in the regulatory region of the IgE germline gene (20). There it functionally interacts with other constitutively bound factors such as C/EBP (21), PU.1 (22), and two different sets of NF-B/Rel family members (23)(24)(25).…”
Section: Interleukin-4 (Il-4)mentioning
confidence: 99%